Fractalkine and CX3CR1 Mediate a Novel Mechanism of Leukocyte Capture, Firm Adhesion, and Activation under Physiologic Flow
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Leukocyte migration into sites of inflammation involves multiple molecular interactions between leukocytes and vascular endothelial cells, mediating sequential leukocyte capture, rolling, and firm adhesion. In this study, we tested the role of molecular interactions between fractalkine (FKN), a transmembrane mucin-chemokine hybrid molecule expressed on activated endothelium, and its receptor (CX3CR1) in leukocyte capture, firm adhesion, and activation under physiologic flow conditions. Immobilized FKN fusion proteins captured resting peripheral blood mononuclear cells at physiologic wall shear stresses and induced firm adhesion of resting monocytes, resting and interleukin (IL)-2–activated CD8+ T lymphocytes and IL-2–activated NK cells. FKN also induced cell shape change in firmly adherent monocytes and IL-2–activated lymphocytes. CX3CR1-transfected K562 cells, but not control K562 cells, firmly adhered to FKN-expressing ECV-304 cells (ECV-FKN) and tumor necrosis factor α–activated human umbilical vein endothelial cells. This firm adhesion was not inhibited by pertussis toxin, EDTA/EGTA, or antiintegrin antibodies, indicating that the firm adhesion was integrin independent. In summary, FKN mediated the rapid capture, integrin-independent firm adhesion, and activation of circulating leukocytes under flow. Thus, FKN and CX3CR1 mediate a novel pathway for leukocyte trafficking.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
Springer, T. A. (1994) · Cell · doi:10.1016/0092-8674(94)90337-9 · Cited by 6,929
Lymphocyte Homing and Homeostasis
Butcher, E. C., & Picker, L. J. (1996) · Science · doi:10.1126/science.272.5258.60 · Cited by 2,846
A new class of membrane-bound chemokine with a CX3C motif
Bazan, J. F., Bacon, K. B., Hardiman, G., Wang, W., Soo, K., Rossi, D., Greaves, D. R., Zlotnik, A., & Schall, T. J. (1997) · Nature · doi:10.1038/385640a0 · Cited by 2,013
Imai, T., Hieshima, K., Haskell, C., Baba, M., Nagira, M., Nishimura, M., Kakizaki, M., Takagi, S., Nomiyama, H., Schall, T. J., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80438-9 · Cited by 1,445
Self-citationSelectins: Interpreters of Cell-Specific Carbohydrate Information During Inflammation
Lasky, L. A. (1992) · Science · doi:10.1126/science.1439808 · Cited by 1,236
Chemokines and the Arrest of Lymphocytes Rolling Under Flow Conditions
Campbell, J. J., Hedrick, J., Zlotnik, A., Siani, M. A., Thompson, D. A., & Butcher, E. C. (1998) · Science · doi:10.1126/science.279.5349.381 · Cited by 995
Varki, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7390 · Cited by 946
The selecting: vascular adhesion molecules
Tedder, T. F., Steeber, D. A., Chen, A., & Engel, P. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.10.7542213 · Cited by 924
Self-citationNeurotactin, a membrane-anchored chemokine upregulated in brain inflammation
Pan, Y., Lloyd, C., Zhou, H., Dolich, S., Deeds, J., Gonzalo, J.-A., Vath, J., Gosselin, M., Ma, J., Dussault, B., et al. (1997) · Nature · doi:10.1038/42491 · Cited by 644
Yoshida, R., Imai, T., Hieshima, K., Kusuda, J., Baba, M., Kitaura, M., Nishimura, M., Kakizaki, M., Nomiyama, H., & Yoshie, O. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.21.13803 · Cited by 394
Self-citation
Cited by
Blood Monocytes Consist of Two Principal Subsets with Distinct Migratory Properties
Geissmann, F., Jung, S., & Littman, D. R. (2003) · Immunity · doi:10.1016/s1074-7613(03)00174-2 · Cited by 3,391
Jung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., & Littman, D. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4106-4114.2000 · Cited by 2,632
“In vitro data show that this firm adhesion is signaling independent and does not involve integrin activation, and may thus represent a novel mechanism in leukocyte trafficking (4, 7).”
BackgroundResultThe many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523
Monitoring of Blood Vessels and Tissues by a Population of Monocytes with Patrolling Behavior
Auffray, C., Fogg, D., Garfa, M., Elain, G., Join-Lambert, O., Kayal, S., Sarnacki, S., Cumano, A., Lauvau, G., & Geissmann, F. (2007) · Science · doi:10.1126/science.1142883 · Cited by 1,973
International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors
Murphy, P. M., Baggiolini, M., Charo, I. F., Hébert, C. A., Horuk, R., Matsushima, K., Miller, L. H., Oppenheim, J. J., & Power, C. A. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01439-x · Cited by 1,817
Optical coherence tomography angiography
Spaide, R. F., Fujimoto, J. G., Waheed, N. K., Sadda, S. R., & Staurenghi, G. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.11.003 · Cited by 1,779
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,701
Lymphocyte traffic control by chemokines
Moser, B., & Loetscher, P. (2001) · Nature Immunology · doi:10.1038/84219 · Cited by 1,240
Bachelerie, F., Ben-Baruch, A., Burkhardt, A. M., Combadiere, C., Farber, J. M., Graham, G. J., Horuk, R., Sparre-Ulrich, A. H., Locati, M., Luster, A. D., et al. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.007724 · Cited by 850
Self-citationChemokine receptors and their role in inflammation and infectious diseases
Murdoch, C., & Finn, A. (2000) · Blood · doi:10.1182/blood.v95.10.3032 · Cited by 839
Mechanisms of disease: pulmonary arterial hypertension
Schermuly, R. T., Ghofrani, H. A., Wilkins, M. R., & Grimminger, F. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.87 · Cited by 800
Chemokines in the Pathogenesis of Vascular Disease
Charo, I. F., & Taubman, M. B. (2004) · Circulation Research · doi:10.1161/01.res.0000146672.10582.17 · Cited by 752
Chieppa, M., Rescigno, M., Huang, A. Y. C., & Germain, R. N. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061884 · Cited by 713
Hundhausen, C., Misztela, D., Berkhout, T. A., Broadway, N., Saftig, P., Reiss, K., Hartmann, D., Fahrenholz, F., Postina, R., Matthews, V., et al. (2003) · Blood · doi:10.1182/blood-2002-12-3775 · Cited by 713
The Role of Glia in the Spinal Cord in Neuropathic and Inflammatory Pain
Old, E. A., Clark, A. K., & Malcangio, M. (2015) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-662-46450-2_8 · Cited by 655
Garton, K. J., Gough, P. J., Blobel, C. P., Murphy, G., Greaves, D. R., Dempsey, P. J., & Raines, E. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106434200 · Cited by 639
Inflammation in pulmonary arterial hypertension
Dorfmüller, P., Perros, F., Balabanian, K., & Humbert, M. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00038903 · Cited by 594
Molecular pathology of age-related macular degeneration
Ding, X., Patel, M., & Chan, C.-C. (2009) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.10.001 · Cited by 582
“When bound by its ligand, CX3CL1 (also known as fractalkine), CX3CR1 mediates mobilization of leukocytes to inflamed tissues and subsequent activation of these inflammatory cells (Fong et al., 1998).”
BackgroundFractalkine Preferentially Mediates Arrest and Migration of CD16+ Monocytes
Ancuta, P., Rao, R., Moses, A., Mehle, A., Shaw, S. K., Luscinskas, F. W., & Gabuzda, D. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022156 · Cited by 570
The trafficking of natural killer cells
Grégoire, C., Chasson, L., Luci, C., Tomasello, E., Geissmann, F., Vivier, E., & Walzer, T. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00563.x · Cited by 569
Monocyte-Endothelial Cell Interactions in the Development of Atherosclerosis
Mestas, J., & Ley, K. (2008) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2008.11.004 · Cited by 548
CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival
Landsman, L., Bar-On, L., Zernecke, A., Kim, K.-W., Krauthgamer, R., Shagdarsuren, E., Lira, S. A., Weissman, I. L., Weber, C., & Jung, S. (2009) · Blood · doi:10.1182/blood-2008-07-170787 · Cited by 490
Decreased atherosclerosis in CX3CR1–/– mice reveals a role for fractalkine in atherogenesis
Lesnik, P., Haskell, C. A., & Charo, I. F. (2003) · Journal of Clinical Investigation · doi:10.1172/jci15555 · Cited by 487
“As a full-length transmembrane protein, FK acts as an adhesion molecule and efficiently captures cells under physiological flow conditions (8, 9).”
Decreased Atherosclerotic Lesion Formation in CX3CR1/Apolipoprotein E Double Knockout Mice
Combadière, C., Potteaux, S., Gao, J.-L., Esposito, B., Casanova, S., Lee, E. J., Debré, P., Tedgui, A., Murphy, P. M., & Mallat, Z. (2003) · Circulation · doi:10.1161/01.cir.0000057548.68243.42 · Cited by 476
CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein
Tripp, R. A., Jones, L. P., Haynes, L. M., Zheng, H., Murphy, P. M., & Anderson, L. J. (2001) · Nature Immunology · doi:10.1038/90675 · Cited by 456
Chazaud, B., Sonnet, C., Lafuste, P., Bassez, G., Rimaniol, A.-C., Poron, F., Authier, F.-J., Dreyfus, P. A., & Gherardi, R. K. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200212046 · Cited by 452
Bulenger, S., Marullo, S., & Bouvier, M. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.01.004 · Cited by 448
Abel, S., Hundhausen, C., Mentlein, R., Schulte, A., Berkhout, T. A., Broadway, N., Hartmann, D., Sedlacek, R., Dietrich, S., Muetze, B., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.6362 · Cited by 437
Yoshie, O., Imai, T., & Nomiyama, H. (2001) · Advances in Immunology · doi:10.1016/s0065-2776(01)78002-9 · Cited by 429
Self-citationAuffray, C., Fogg, D. K., Narni-Mancinelli, E., Senechal, B., Trouillet, C., Saederup, N., Leemput, J., Bigot, K., Campisi, L., Abitbol, M., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081385 · Cited by 422
Holt, M. P., Cheng, L., & Ju, C. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0308173 · Cited by 399
Maciejewski-Lenoir, D., Chen, S., Feng, L., Maki, R., & Bacon, K. B. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1628 · Cited by 357
Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease
Moatti, D. (2001) · Blood · doi:10.1182/blood.v97.7.1925 · Cited by 349
Chemokines in the CNS: plurifunctional mediators in diverse states
Asensio, V. C., & Campbell, I. L. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01453-8 · Cited by 345
Neuropathic pain and cytokines: current perspectives
Malcangio, M., Clark, A. K., & Old, E. A. (2013) · Journal of Pain Research · doi:10.2147/jpr.s53660 · Cited by 337
Nishimura, M., Umehara, H., Nakayama, T., Yoneda, O., Hieshima, K., Kakizaki, M., Dohmae, N., Yoshie, O., & Imai, T. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6173 · Cited by 326
Self-citationGrabovsky, V., Feigelson, S., Chen, C., Bleijs, D. A., Peled, A., Cinamon, G., Baleux, F., Arenzana-Seisdedos, F., Lapidot, T., van Kooyk, Y., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.495 · Cited by 324
Faure, S., Meyer, L., Costagliola, D., Vaneensberghe, C., Genin, E., Autran, B., ALT, F., Groups, I. S., Delfraissy, J.-F., Group, S. S., et al. (2000) · Science · doi:10.1126/science.287.5461.2274 · Cited by 323
Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses
Fraticelli, P., Sironi, M., Bianchi, G., D’Ambrosio, D., Albanesi, C., Stoppacciaro, A., Chieppa, M., Allavena, P., Ruco, L., Girolomoni, G., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11517 · Cited by 321
Fractalkine in Vascular Biology: From Basic Research to Clinical Disease
Umehara, H., Bloom, E. T., Okazaki, T., Nagano, Y., Yoshie, O., & Imai, T. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000095360.62479.1f · Cited by 319
Self-citationCigarette Smoke–induced Emphysema: A Role for the B Cell?
van der Strate, B. W. A., Postma, D. S., Brandsma, C.-A., Melgert, B. N., Luinge, M. A., Geerlings, M., Hylkema, M. N., van den Berg, A., Timens, W., & Kerstjens, H. A. M. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200504-594oc · Cited by 311
Ishida, Y., Gao, J.-L., & Murphy, P. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.1.569 · Cited by 310
Microglia in Health and Disease
Ransohoff, R. M., & Khoury, J. E. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020560 · Cited by 303
CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-α levels
Blankenberg, S., Espinola-Klein, C., Dopheide, J., Bickel, C., Lackner, K., Iz, M., Meyer, J., Darius, H., Rupprecht, H., Schlitt, A., et al. (2004) · Thrombosis and Haemostasis · doi:10.1160/th04-02-0095 · Cited by 301
Role of Inflammation in Atherosclerosis
Spagnoli, L. G., Bonanno, E., Sangiorgi, G., & Mauriello, A. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.038661 · Cited by 293
McDermott, D. H., Fong, A. M., Yang, Q., Sechler, J. M., Cupples, L. A., Merrell, M. N., Wilson, P. W. F., D’Agostino, R. B., O’Donnell, C. J., Patel, D. D., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16790 · Cited by 281
Self-citationEbnet, K., & Vestweber, D. (1999) · Histochemistry and Cell Biology · doi:10.1007/s004180050387 · Cited by 278
In vivo structure/function and expression analysis of the CX3C chemokine fractalkine
Kim, K.-W., Vallon-Eberhard, A., Zigmond, E., Farache, J., Shezen, E., Shakhar, G., Ludwig, A., Lira, S. A., & Jung, S. (2011) · Blood · doi:10.1182/blood-2011-04-348946 · Cited by 277
CX 3 C Chemokine Fractalkine in Pulmonary Arterial Hypertension
Balabanian, K., Foussat, A., Dorfmüller, P., Durand-Gasselin, I., Capel, F., Bouchet-Delbos, L., Portier, A., Marfaing-Koka, A., Krzysiek, R., Rimaniol, A.-C., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2106007 · Cited by 274
McDermott, D. H., Halcox, J. P. J., Schenke, W. H., Waclawiw, M. A., Merrell, M. N., Epstein, N., Quyyumi, A. A., & Murphy, P. M. (2001) · Circulation Research · doi:10.1161/hh1701.095642 · Cited by 256
Nakayama, T., Hieshima, K., Izawa, D., Tatsumi, Y., Kanamaru, A., & Yoshie, O. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1136 · Cited by 256
Self-citationThe blood-brain barrier, chemokines and multiple sclerosis
Holman, D. W., Klein, R. S., & Ransohoff, R. M. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.019 · Cited by 247
“CX3CL1 is expressed by TNF-α- and IL-1-activated endothelium within the kidney and heart where it induces integrinindependent leukocyte capture, acting as an adhesion molecule [92–94].”
BackgroundChemokines: Key Regulators of Mononuclear Cell Recruitment in Atherosclerotic Vascular Disease
Weber, C., Schober, A., & Zernecke, A. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000142812.03840.6f · Cited by 244
Molecular Uncoupling of Fractalkine-mediated Cell Adhesion and Signal Transduction
Haskell, C. A., Cleary, M. D., & Charo, I. F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.15.10053 · Cited by 235
CX3CR1-dependent renal macrophage survival promotes Candida control and host survival
Lionakis, M. S., Swamydas, M., Fischer, B. G., Plantinga, T. S., Johnson, M. D., Jaeger, M., Green, N. M., Masedunskas, A., Weigert, R., Mikelis, C., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci71307 · Cited by 230
“org Volume 123 Number 12 December 2013 5039 properties (23).”
Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury
Soriano, S. G., Amaravadi, L. S., Wang, Y. F., Zhou, H., Yu, G. X., Tonra, J. R., Fairchild-Huntress, V., Fang, Q., Dunmore, J. H., Huszar, D., et al. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00033-4 · Cited by 222
“Secreted FKN facilitates leukocyte migration along directional concentration gradients (Fong et al., 1998).”
BackgroundInfluentialTuo, J., Smith, B. C., Bojanowski, C. M., Meleth, A. D., Gery, I., Csaky, K. G., Chew, E. Y., & Chan, C.-C. (2004) · The FASEB Journal · doi:10.1096/fj.04-1862fje · Cited by 215
Aoyama, T., Inokuchi, S., Brenner, D. A., & Seki, E. (2010) · Hepatology · doi:10.1002/hep.23795 · Cited by 211
Rustenhoven, J., Aalderink, M., Scotter, E. L., Oldfield, R. L., Bergin, P. S., Mee, E. W., Graham, E. S., Faull, R. L. M., Curtis, M. A., Park, T. I.-H., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0503-0 · Cited by 201
Cardozo, A. K., Proost, P., Gysemans, C., Chen, M.-C., Mathieu, C., & Eizirik, D. L. (2003) · Diabetologia · doi:10.1007/s00125-002-1017-0 · Cited by 196
“Fractalkine has adhesive properties, promoting leukocyte migration and enhancing the cytotoxicity of NK cells [27] and cytotoxic T-lymphocytes [ 28 ].”
BackgroundTang, Z., Gan, Y., Liu, Q., Yin, J.-X., Liu, Q., Shi, J., & Shi, F.-D. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-26 · Cited by 193
“CX3CL1/CX3CR1 also regulates recruitment of circulating leukocytes to sites of injury [8,9].”
BackgroundEffector Mechanisms of Rejection
Moreau, A., Varey, E., Anegon, I., & Cuturi, M.-C. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a015461 · Cited by 189
“Fractalkine acts as a chemoattractant and adhesion molecule for cells that express CX3CR1, including certain immune cells such as monocytes/macrophages, NK cells, and T cells (Imai et al. 1997; Fong et al. 1998; Foussat et al. 2000).”
BackgroundLy6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy
Jung, K., Heishi, T., Khan, O. F., Kowalski, P. S., Incio, J., Rahbari, N. N., Chung, E., Clark, J. W., Willett, C. G., Luster, A. D., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci93182 · Cited by 164
Fractalkine Is a Novel Human Adipochemokine Associated With Type 2 Diabetes
Shah, R., Hinkle, C. C., Ferguson, J. F., Mehta, N. N., Li, M., Qu, L., Lu, Y., Putt, M. E., Ahima, R. S., & Reilly, M. P. (2011) · Diabetes · doi:10.2337/db10-0956 · Cited by 169
“The soluble form of CX3CL1, cleaved from the membrane by the enzyme ADAM17 or TACE (TNF-a converting enzyme), may be involved in chemotaxis, while the membrane-anchored form promotes adhesion and retention of leukocytes (40).”
BackgroundLucas, A. D., Chadwick, N., Warren, B. F., Jewell, D. P., Gordon, S., Powrie, F., & Greaves, D. R. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64034-5 · Cited by 165
“Cell adhesion to immobilized forms of fractalkine or transfected cells expressing full-length fractalkine can occur under flow conditions in vitro.(6,7) Binding to immobilized forms of fractalkine does not require G-protein signaling, does not require the mucin stalk, and can occur via an integrin-independent pathway.”
BackgroundIsse, K., Harada, K., Zen, Y., Kamihira, T., Shimoda, S., Harada, M., & Nakanuma, Y. (2005) · Hepatology · doi:10.1002/hep.20582 · Cited by 158
Mechanisms of Mononuclear Phagocyte Recruitment in Alzheimers Disease
Hickman, S. E., & Khoury, J. E. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710791011982 · Cited by 120
“In contrast, the CX3CL1/CX3CR1 pathway appears to control monocyte capture and firm adhesion at the blood vessel to tissue barrier [54, 55].”
BackgroundD'Haese, J. G., Demir, I. E., Friess, H., & Ceyhan, G. O. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903540265 · Cited by 116
“On the one hand, fractalkine stimulates a strong immune response leading to the recruitment of NK cells and tumor-specific T-cells.”
BackgroundInfluentialThe CX3C chemokine fractalkine in allergic asthma and rhinitis
Rimaniol, A.-C., Till, S. J., Garcia, G., Capel, F., Godot, V., Balabanian, K., Durand-Gasselin, I., Varga, E. M., Simonneau, G., Emilie, D., et al. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.09.041 · Cited by 87
Glucocorticoid signaling in myeloid cells worsens acute CNS injury and inflammation
Sorrells, S. F., Caso, J. R., Munhoz, C. D., Hu, C. K., Tran, K. V., Miguel, Z. D., Chien, B. Y., & Sapolsky, R. M. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.4705-12.2013 · Cited by 46
“In contrast to its CNS role as a suppressive inflammatory mediator released by neurons, soluble CX3CL1 can promote the recruitment of peripheral immune cells to injury, increasing stroke infarct volume (Fong et al., 1998; Soriano et al., 2002).”
Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in periodontal diseased tissue
Hosokawa, Y., Nakanishi, T., Yamaguchi, D., Nakae, H., & Matsuo, T. (2005) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2005.02675.x · Cited by 39
The effect of CX3CL1/ CX3CR1 signal axis on microglia in central nervous system diseases
Zhao, J., Li, Q., Ouyang, X., Wang, F., Li, Q., Xu, Z., Ji, D., Wu, Q., Zhang, J., Lu, C., et al. (2023) · Journal of Neurorestoratology · doi:10.1016/j.jnrt.2023.100042 · Cited by 29
Investigating the ATP-binding pocket of CX3CL1-binding protein 2 using in silico approach
Kumari, R., Kaur, S., Hora, R., & Mishra, P. C. (2024) · Journal of Proteins and Proteomics · doi:10.1007/s42485-024-00133-z
Metadata
- Authors
- Fong, A. M., Robinson, L. A., Steeber, D. A., Tedder, T. F., Yoshie, O., Imai, T., & Patel, D. D.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1998-10-19
- Volume
- 188
- Issue
- 8
- Pages
- 1413-1419
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2147303583
- Cited by
- 679
- References
- 26
- FWCI
- 10.55
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.